• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pfizer

    Tag: Pfizer

    CDC backs FDA authorization of boosters for healthy 12- to 15-year-olds despite safety concerns
    Healthcare

    CDC backs FDA authorization of boosters for healthy 12- to 15-year-olds despite safety concerns

    Cassidy Morrison -
    January 6, 2022 3:11 am
    0
    FDA authorizes Pfizer-BioNTech COVID vaccine booster for children ages 12-15
    News

    FDA authorizes Pfizer-BioNTech COVID vaccine booster for children ages 12-15

    Asher Notheis -
    January 3, 2022 12:00 am
    0
    New York prioritizes nonwhite people in COVID-19 treatment distribution plan
    News

    New York prioritizes nonwhite people in COVID-19 treatment distribution plan

    Misty Severi -
    January 1, 2022 12:53 am
    0
    FDA authorizes first antiviral to treat COVID-19
    Healthcare

    FDA authorizes first antiviral to treat COVID-19

    Cassidy Morrison -
    December 22, 2021 6:02 pm
    0
    Early signs indicate omicron may pose less of threat
    Healthcare

    Early signs indicate omicron may pose less of threat

    Cassidy Morrison -
    December 22, 2021 12:00 pm
    0
    A monitor displays Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, June 9, 2017.
    Business

    Pfizer enters medical marijuana industry with $6.7 billion cannabis bet

    Luke Gentile -
    December 20, 2021 11:01 pm
    0
    Pfizer vaccine fails to produce immune response in children 2-5 in trial
    Healthcare

    Pfizer vaccine fails to produce immune response in children 2-5 in trial

    Cassidy Morrison -
    December 17, 2021 8:40 pm
    0
    CDC panel recommends mRNA vaccines over Johnson & Johnson due to blood clotting risk
    Healthcare

    CDC panel recommends mRNA vaccines over Johnson & Johnson due to blood clotting risk

    Cassidy Morrison -
    December 16, 2021 9:22 pm
    0
    This May 4, 2014 photo shows the Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York. The pharmaceutical giant reports quarterly financial results on Tuesday, July 29, 2014.
    Beltway Confidential

    Why won’t Congress or the Biden administration save lives by approving Pfizer’s antiviral drug tomorrow?

    Timothy P. Carney -
    December 14, 2021 6:35 pm
    0
    Pfizer says COVID-19 pill 89% effective against severe illness
    Healthcare

    Pfizer says COVID-19 pill 89% effective against severe illness

    Cassidy Morrison -
    December 14, 2021 2:54 pm
    0
    1...789...35Page 8 of 35
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter